Support comprehensive treatment for pain and substance use disorders
Heading
The AMA urges all health insurance companies and other payers to remove administrative and other barriers to patient care.
Share Your Story
The AMA wants to hear directly from physicians how they are responding to the nation’s opioid epidemic. By sharing your story, you will help inform AMA advocacy in our work on behalf of physicians and patients.
Heading
American Society of Anesthesiologists’ resources on pain management and anesthesia
Learn more about anesthesia, pain management and the medical experts committed to patient safety and high-quality care.
Enhanced Attestation of Mental Health and Substance Use Disorder Parity
Use of this form by state regulators–and health insurers–can help ensure meaningful state oversight and compliance with the federal Mental Health Parity and Addiction Equity Act. This guides health insurers through the necessary analysis to demonstrate compliance with the law, which can then be made available to a state department of insurance to streamline regulatory review.
AMA Education Hub: Opioid and Pain Management: Guidelines, Research and Treatments
Fulfill your state-mandated CME credits while enhancing your knowledge of opioid and non-opioid pain management, safe opioid prescribing and substance use treatment. Learn now.
CME 44.25 Total Credits
What does a sufficient pain care formulary look like?
The AMA believes it is essential for formularies to also include a broad range of evidence-based pain care options. This resource is meant to provide an overview for policymakers of the types of treatments practicing physicians use to treat pain but may be subject to formulary exclusion or administrative barriers such as prior authorization or step therapy, or subject to cost-prohibitive co-pays, cost sharing and adverse formulary tiering.
Opioid Overdose Prevention Toolkit (En Español)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Finding Quality Treatment for Substance Use Disorders (Spanish Version)
Buscar Tratamiento De Calidad Para Trastornos De Uso De Sustancias
Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids
Given the complex needs of pregnant and postpartum women and their children, and the number of systems they encounter during critically important periods in their lives, ASAM provides policy recommendations on substance use, misuse, and SUDs during and following pregnancy.
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System
JAMA Psychiatry
Public Policy Statement on the Regulation of Office-Based Opioid Treatment
Learn More
Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy
AMA Journal of Ethics. September 2017, Volume 19, Number 9: 922-930.
Sarah E. Wakeman, MD
A Primer on Antagonist-Based Treatment of Opioid Use Disorders in the Office Setting
Learn More